Bauckneht, M., Capitanio, S., Donegani, M. I., Zanardi, E., Miceli, A., Murialdo, R., . . . Morbelli, S. (2019). Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223. Cancers (Basel).
Citación estilo ChicagoBauckneht, Matteo, et al. "Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223." Cancers (Basel) 2019.
Cita MLABauckneht, Matteo, et al. "Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223." Cancers (Basel) 2019.